Clincosm LogoSign in Get a demo

Metastatic Castration-Resistant Prostate Cancer

Showing 26 - 50 of 116
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Harboring NRG1 Fusion, Metastatic Castration-resistant Prostate Cancer Trial in Whittier, Lake Mary (Afatinib Oral Tablet,

Recruiting
  • NSCLC Harboring NRG1 Fusion
  • Metastatic Castration-resistant Prostate Cancer
  • Afatinib Oral Tablet
  • +3 more
  • Whittier, California
  • +1 more
Dec 20, 2022

Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Herlev

Recruiting
  • Prostate Cancer Metastatic
  • +3 more
  • Stereotactic body radiotherapy
  • +3 more
  • Herlev, Capital Region, Denmark
    Department of Oncology, Copenhagen University Hospital Herlev an
Dec 16, 2022

Metastatic Castration-Resistant Prostate Cancer Trial (Talazoparib)

Available
  • Metastatic Castration-Resistant Prostate Cancer
  • (no location specified)
Dec 6, 2022

Non Small Cell Lung Cancer, Urothelial Cancer, Ovarian Cancer Trial in United States (XB002, Nivolumab)

Recruiting
  • Non Small Cell Lung Cancer
  • +9 more
  • Saint Louis, Missouri
  • +4 more
Dec 12, 2022

Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in Worldwide (acapatamab, Pembrolizumab, Etanercept)

Active, not recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Prostate Cancer
  • Campbell, California
  • +29 more
Dec 6, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Korea, Republic of, United States (Phase I and Phase II:

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Phase I and Phase II: LAE001/prednisone + afuresertib
  • Tucson, Arizona
  • +16 more
Nov 30, 2022

Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer Trial in

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • +2 more
  • Vancouver, British Columbia, Canada
    BC Cancer
Nov 28, 2022

Metastatic Castration-resistant Prostate Cancer Trial in San Francisco, Providence (Rucaparib, Copanlisib)

Active, not recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • San Francisco, California
  • +1 more
Nov 22, 2022

Prostatic Tumors, Castration-Resistant, Tumors by Histologic Type, Tumors, Prostate Trial in United States (P-PSMA-101 CAR-T

Active, not recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • +16 more
  • Duarte, California
  • +9 more
Nov 15, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Cabozantinib)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Salt Lake City, Utah
    Huntsman Cancer Institute at University of Utah
Nov 10, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Beijing (1.11 GBq (30 mCi) of 177Lu-PSMA-EB-01, 1.85 GBq (50 mCi) of

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • 1.11 GBq (30 mCi) of 177Lu-PSMA-EB-01
  • +2 more
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Nov 6, 2022

Metastatic Castration-resistant Prostate Cancer Trial in United States (drug, radiation, device)

Completed
  • Metastatic Castration-resistant Prostate Cancer
  • NKTR-214 (Cohort A)
  • +6 more
  • Los Angeles, California
  • +5 more
Nov 10, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Bellinzona, Chur, St. Gallen (Docetaxel micellar)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Docetaxel micellar
  • Bellinzona, Switzerland
  • +2 more
Nov 7, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Beijing (1.1 GBq (30 mCi) of 177Lu-P17-087, 1.1 GBq (30 mCi) of

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • 1.1 GBq (30 mCi) of 177Lu-P17-087
  • 1.1 GBq (30 mCi) of 177Lu-P17-088
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Oct 30, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Myrtle Beach (Darolutamide, Enzalutamide, Radium-223)

Terminated
Has Results
  • Metastatic Castration-resistant Prostate Cancer
  • Enzalutamide during Lead-in Period
  • +5 more
  • Myrtle Beach, South Carolina
    Research Site
Sep 9, 2022

Metastatic Castration-resistant Prostate Cancer Trial in United Kingdom, United States (PLX2853, Olaparib, Abiraterone acetate)

Terminated
  • Metastatic Castration-resistant Prostate Cancer
  • Chicago, Illinois
  • +7 more
Oct 4, 2022

Metastatic Castration-resistant Prostate Cancer, mCRPC, Prostate Cancer Trial in Melbourne (Lutetium-177 PSMA-I&T, Radium-223)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • +2 more
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Sep 26, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Grand Rapids (illuccix 68Ga-PSMA-11 Total Body PET-CT)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • illuccix 68Ga-PSMA-11 Total Body PET-CT
  • Grand Rapids, Michigan
    BAMF Health
Sep 26, 2022

Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Boston (Abemaciclib, Atezolizumab)

Recruiting
  • Prostate Cancer
  • Metastatic Castration-resistant Prostate Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Sep 26, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Mexico City (SV-102)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Mexico City, Mexico
    Hospital Diomed
Sep 14, 2022

Metastatic Cancer, Metastatic Breast Cancer, Metastatic Lung Cancer Trial in Mexico City (SV-101)

Recruiting
  • Metastatic Cancer
  • +3 more
  • Mexico City, Mexico
    Hospital Diomed
Sep 14, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +6 more
  • San Francisco, California
    University of California, San Francisco
Sep 8, 2022

Metastatic Castration-resistant Prostate Cancer Trial (Niraparib plus Abiraterone Acetate (Nira/AA) combination,

Available
  • Metastatic Castration-resistant Prostate Cancer
  • (no location specified)
Aug 24, 2022

Metastatic Castration-Resistant Prostate Cancer Trial in China, United States (ZEN003694, Enzalutamide)

Recruiting
  • Metastatic Castration-Resistant Prostate Cancer
  • San Francisco, California
  • +21 more
Aug 18, 2022

Tumor Malignant, Renal Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma Trial in Worldwide (XL092, Atezolizumab,

Recruiting
  • Neoplasm Malignant
  • +5 more
  • Duarte, California
  • +55 more
Aug 17, 2022